Literature DB >> 8108755

Detection of the tetM determinant in Neisseria gonorrhoeae.

C A Ison1, N Tekki, M J Gill.   

Abstract

BACKGROUND AND OBJECTIVES: Plasmid-mediated high level resistance to tetracycline in Neisseria gonorrhoeae has become a therapeutic problem in many parts of the world. Simple, fast and accurate screening tests are required to enable rapid detection. GOAL OF THE STUDY: To evaluate screening tests for high-level tetracycline resistance for their ability to predict the presence of the tetM determinant in Neisseria gonorrhoeae. STUDY
DESIGN: Strains considered to exhibit plasmid-mediated (90) and chromosomal resistance (19) to tetracycline were used to compare the screening tests, growth on tetracycline agar, disc testing, MIC and plasmid content, with confirmation by hybridization to the tetM probe. A polymerase chain reaction to amplify tetM in N. gonorrhoeae was also evaluated.
RESULTS: All strains defined as presumptive TRNG by the screening tests hybridized with the tetM probe. None of the low-level resistant strains were positive in the screening tests or hybridized with the probe. In addition, the polymerase chain reaction (PCR) on whole bacterial cells detected tetM in all TRNG tested. Restriction enzyme digests of the PCR product gave three patterns suggesting genetic diversity within the tetM determinant of N. gonorrhoeae.
CONCLUSION: Simple screening tests were found to be reliable predictors of TRNG. tetM was detected by PCR in all strains tested and exhibited some genetic variation that may be of use for epidemiological typing.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8108755

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  9 in total

1.  Molecular epidemiology of tetM genes in Neisseria gonorrhoeae.

Authors:  A Turner; K R Gough; J P Leeming
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

2.  Susceptibility of gonococci isolated in London to therapeutic antibiotics: establishment of a London surveillance programme. London Gonococcal Working Group.

Authors:  C A Ison; I M Martin
Journal:  Sex Transm Infect       Date:  1999-04       Impact factor: 3.519

Review 3.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Characterisation of high level tetracycline resistant Neisseria gonorrhoeae isolates.

Authors:  T Kuroki; T Murase; Y Watanabe; Y Asai; S Yamai; S Nakayama; A Wada; H Watanabe
Journal:  Genitourin Med       Date:  1997-10

Review 5.  Antimicrobial agents and gonorrhoea: therapeutic choice, resistance and susceptibility testing.

Authors:  C A Ison
Journal:  Genitourin Med       Date:  1996-08

6.  Characteristics of gonococci isolated from men with urethritis in Dubai.

Authors:  K Al-Hattawi; C A Ison
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

7.  A one-year survey of Neisseria gonorrhoeae isolated from patients attending an east London genitourinary medicine clinic: antibiotic susceptibility patterns and patients' characteristics.

Authors:  D A Lewis; C A Ison; D M Livermore; H Y Chen; A Y Hooi; A R Wisdom
Journal:  Genitourin Med       Date:  1995-02

8.  Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles.

Authors:  T Deguchi; M Yasuda; M Nakano; S Ozeki; T Ezaki; I Saito; Y Kawada
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  Conjugative plasmids of Neisseria gonorrhoeae.

Authors:  Emilia Pachulec; Chris van der Does
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.